Endo Health Solutions Inc

More

• RESEARCH ALERT-Endo Health Solutions: JP Morgan raises price target Monday, 6 May 2013 | 1:32 AM ET

  May 6- Endo Health Solutions Inc:. *JP Morgan raises price target to $39 from $35. Reuters Station users, click. 1568.

• UPDATE 1-US panel divided over safety of Endo's testosterone drug Thursday, 18 Apr 2013 | 5:27 PM ET

  April 18- An advisory panel to the U.S. Food and Drug Administration was sharply divided on Thursday over whether a drug made by Endo Health Solutions Inc can safely be prescribed for men with low testosterone.

• U.S. FDA panel deadlocked over Endo's testosterone drug Thursday, 18 Apr 2013 | 3:38 PM ET

  April 18- An advisory panel to the U.S. Food and Drug Administration was deadlocked over whether the agency should approve Endo Health Solutions Inc's experimental drug to treat low testosterone in men. The panel on Thursday voted 9-9 on whether the drug is safe for the treatment of conditions associated with low testosterone.

• After-Hours Buzz: GPS, CRM, GRPN & More Thursday, 28 Feb 2013 | 3:40 PM ET

  

  Check out which companies are making headlines after the bell Thursday:

• REFILE-UPDATE 2-Jury awards $3.35 mln in vaginal mesh case against J&J Monday, 25 Feb 2013 | 3:25 PM ET

  ATLANTIC CITY, N.J., Feb 25- A jury on Monday said Johnson& Johnson should pay a South Dakota woman $3.35 million for failing to adequately warn her doctor of the potential dangers of a vaginal mesh implant made by the company's Ethicon subsidiary, and for misrepresenting the product in brochures.

• EXCLUSIVE-Endo Health in talks with potential buyers-sources Wednesday, 30 Jan 2013 | 3:35 PM ET

  *Warner Chilcott, Valeant Pharmaceuticals among interested parties-sources. NEW YORK, Jan 30- Endo Health Solutions Inc has held talks in recent weeks with drugmakers potentially interested in buying the maker of pain relief medication, people familiar with the matter said on Wednesday.

• After-Hours Buzz: CSTR, PRGS & More Thursday, 3 Jan 2013 | 4:39 PM ET

  

  Check out which companies are making headlines after the bell Thursday:

• Mylan recalls painkiller pills made by Qualitest Thursday, 20 Dec 2012 | 8:06 AM ET

  Dec 20- Generic drug maker Mylan Inc said on Thursday it is recalling three lots of hydrocone bitartrate, the generic name for Vicodin, and acetaminophen tablets because of concerns that a small number of tablets were too large and therefore too strong.

• After-Hours Buzz: Juniper, Boston Beer & More Wednesday, 12 Dec 2012 | 5:42 PM ET

  

  Check out which companies are making headlines after the bell Wednesday.

• Why Samsung Stock Surge Won’t Fizzle Out Like Apple’s Thursday, 22 Nov 2012 | 4:19 AM ET

  

  Shares of Samsung Electronics, which have surged almost 35 percent since the start of the year, closed at an all-time high on Thursday boosted by expectations that its smartphone business will continue to drive strong profit growth.